首页> 中文期刊>中国药物应用与监测 >钠钾镁钙葡萄糖注射液临床使用合理性及安全性分析

钠钾镁钙葡萄糖注射液临床使用合理性及安全性分析

     

摘要

目的:了解我院住院患者钠钾镁钙葡萄糖注射液临床使用情况,旨为临床合理用药提供参考.方法:利用医院信息系统(HIS),汇总2015年10月1日–12月31日我院使用钠钾镁钙葡萄糖注射液的数据,并随机抽取100份病历,对适应证、用法用量、配伍方案、不良反应等进行统计与分析.结果:2015年10月1日–12月31日全院共计使用钠钾镁钙葡萄糖注射液2254例,随机抽取的100份病例中,仅有17例有明确用药指征,4例患者存在用药禁忌症,13例存在潜在的用药配伍禁忌.结论:钠钾镁钙葡萄糖注射液在临床应用中存在不合理用药现象.应严格把握用药指征,避免不规范使用和过度使用,以降低患者药品费用,促进临床合理用药.%Objective: To evaluate the rationality and safety of sodium potassium magnesium calcium and glucose injection in clinical use in our hospital, and provide reference for rational drug use. Methods: By using hospital information system (HIS), a retrospective study was conducted in 100 patients who were treated with sodium potassium magnesium calcium and glucose injection in our hospital during October 1 to December 31 in 2015 and analyzed in respect of the indication, usage and dosage, compatibility regimen, adverse reactions, etc. Results: There were 2254 patients who were treated with sodium potassium magnesium calcium and glucose injection during the investigating period. We selected 100 cases via random allocation and evaluated the rationality of the drug use. Only 17 cases had clear indications. There were contraindications in 4 patients, and 13 cases had potential medicine incompatibility. Conclusion: The unreasonable uses of sodium potassium magnesium calcium and glucose injection included no indication for drug utilization, incompatibility, contraindication, etc. It is suggested that the medical institution should strengthen the administration and supervision, in order to avoid excessive and irrational drug use and reduce the cost of patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号